Skip to main content
Top
Published in: Dermatology and Therapy 2/2024

Open Access 12-01-2024 | Acne | Correction

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Authors: Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson, Sunil Dhawan, Rajeev Chavda, J. P. York, Baldo Sforzolini, Kate Holcomb, Glynis Ablon, James Del Rosso, Brigitte Dreno

Published in: Dermatology and Therapy | Issue 2/2024

Login to get access

Excerpt

Correction: Dermatol Ther (Heidelb) (2023) 13:3085–3096 https://doi.org/10.1007/s13555-023-01042-7
Metadata
Title
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
Authors
Stephen Schleicher
Angela Moore
Elyse Rafal
Angelique Gagne-Henley
Sandra Marchese Johnson
Sunil Dhawan
Rajeev Chavda
J. P. York
Baldo Sforzolini
Kate Holcomb
Glynis Ablon
James Del Rosso
Brigitte Dreno
Publication date
12-01-2024
Publisher
Springer Healthcare
Keyword
Acne
Published in
Dermatology and Therapy / Issue 2/2024
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-023-01090-z

Other articles of this Issue 2/2024

Dermatology and Therapy 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine